T1	Participants 88 114	early rheumatoid arthritis
T2	Participants 338 381	early, nonerosive rheumatoid arthritis (RA)
T3	Participants 391 459	Fifty-seven patients younger than 65 years with early, nonerosive RA
T4	Participants 771 835	7 of the 57 patients (12.3%) withdrew because of adverse events.
T5	Participants 2085 2093	early RA
